MalgorzataMcMastersMD

PubMed

• 80 citations
  Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.
  David P. Steensma, Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji, Jay Yang, Andrew M. Brunner, Hetty E. Carraway, Lionel Ades,...> ;Leukemia. 2021 Jun 25
• Parkinsonism reversed from treatment of pineal non-germinomatous germ cell tumor.
  Sydni M Cole, Sasmit Sarangi, David J. Einstein, Malgorzata McMasters, Ron L. Alterman, Jeffrey N. Bruce, Lauren Hertan, Helen A. Shih, Eric T. Wong> ;Surgical Neurology International. 2021 Jan 1
• 3 citations
  Casting a wider protective net: Anti-infective vaccine strategies for patients with hematologic malignancy and blood and marrow transplantation.
  Malgorzata McMasters, Barbra M. Blair, Hillard M. Lazarus, Carolyn D. Alonso> ;Blood Reviews. 2021 May 1
• 24 citations
  The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH
  Jeffrey I. Zwicker, Tzu-Fei Wang, Daniel J. DeAngelo, Mandy N Lauw, Jean M. Connors, Anna Falanga, Malgorzata McMasters, Marc Carrier> ;Journal of Thrombosis and Haemostasis. 2020 Feb 1
• 21 citations
  Alisertib Plus Induction Chemotherapy in Previously Untreated Patients With High-Risk, Acute Myeloid Leukaemia: A Single-Arm, Phase 2 Trial
  Andrew M. Brunner, Traci M. Blonquist, Daniel J. DeAngelo, Malgorzata McMasters, Geoffrey Fell, Nicole M. Hermance, Eric S. Winer, R. Coleman Lindsley, Gabriela S. Hob...> ;The Lancet. Haematology. 2020 Feb 1
• 44 citations
  Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
  Myrna Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia Rachel Pyzer, Eleni Anastasiadou, Anna Sergeeva, Adam Ephraim, Abigail Washington, Shira Orr, ...> ;British Journal of Haematology. 2019 Mar 3
• 11 citations
  Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor.
  Ioannis Politikos, Malgorzata McMasters, Christine R. Bryke, David Avigan, Vassiliki A. Boussiotis> ;Blood Advances. 2018 Jun 26
• 24 citations
  Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.
  John Koreth, Haesook T. Kim, Paulina B. Lange, Samuel J. Poryanda, Carol Reynolds, Sharmila Chamling Rai, Philippe Armand, Corey Cutler, Vincent T. Ho, Brett Glotzbeck...> ;Haematologica. 2018 Mar 1
• 12 citations
  A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.
  Daniel J. DeAngelo, Andrew M. Brunner, Lillian Werner, David Avigan, Amir T. Fathi, Adam S. Sperling, Abigail Washington, Dina Stroopinsky, Jacalyn Rosenblatt, Malgorz...> ;American Journal of Hematology. 2018 Feb 1
• 22 citations
  Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation.
  Amir T. Fathi, Traci M. Blonquist, Daniela Hernandez, Philip C. Amrein, Karen K. Ballen, Malgorzata McMasters, David Avigan, Robin Joyce, Emma Logan, Gabriela S. Hobbs...> ;Cancer. 2018 Jan 15
• 14 citations
  A multicenter, retrospective, case‐cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients
  Carolyn D. Alonso, David A. Braun, Ishan Patel, Mona Akbari, Daniel Jungmyung Oh, Tomi Jun, Malgorzata McMasters, Sarah P. Hammond, Brett Glotzbecker, Corey Cutler, Da...> ;Transplant Infectious Disease. 2017 Aug 1
• 53 citations
  MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs
  , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2017 May 30
• 115 citations
  MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
  Athalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, Abigail Washington, Ashujit Tagde, Maxwell D. Coll, Jacqueline Fung, Mary Paty Bryant, Leandra Cole, Kristen Palm...> ;Blood. 2017 Mar 30
• 119 citations
  Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
  Jacalyn Rosenblatt, Richard Stone, Lynne Uhl, Donna Neuberg, Robin Joyce, James D. Levine, Jon E. Arnason, Malgorzata McMasters, Katarina Luptakova, Salvia Jain, Jeffr...> ;Science Translational Medicine. 2016 Dec 7
• 24 citations
  Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
  , , , , , , , , , , , , , , , , , , , , , , , , , > ;Blood. 2016 Dec 2
• Join now to see all

Abstracts/Posters

• A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults
  Malgorzata McMasters, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic...
  Malgorzata McMasters, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019